Sector Chart Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 27/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 59.26 USD | -1.30% |
|
+7.26% | +34.53% |
| 08-21 | Scholar Rock's Global Regulatory Path Further De-Risked, Wedbush Says | MT |
| 08-21 | Wedbush Adjusts Scholar Rock Price Target to $64 From $58, Maintains Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 7.31B | - | - | - | - | - |
| 70.42B | |||||
| 65.4B | |||||
| 28.28B | - | ||||
| 26.57B | |||||
| 27.16B | - |
Select your edition
All financial news and data tailored to specific country editions
